J.W. Cole Advisors Inc. Purchases 302 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

J.W. Cole Advisors Inc. raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,437 shares of the company’s stock after buying an additional 302 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in GE HealthCare Technologies were worth $343,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. First Command Advisory Services Inc. grew its holdings in shares of GE HealthCare Technologies by 36,900.0% during the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after purchasing an additional 369 shares during the last quarter. Legacy Financial Group LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $26,000. OFI Invest Asset Management acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $26,000. ORG Partners LLC lifted its position in shares of GE HealthCare Technologies by 174.2% during the 3rd quarter. ORG Partners LLC now owns 425 shares of the company’s stock valued at $29,000 after acquiring an additional 270 shares during the period. Finally, Fortitude Family Office LLC acquired a new position in shares of GE HealthCare Technologies during the 4th quarter valued at $29,000. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently issued reports on GEHC. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their target price for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Evercore ISI boosted their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Argus boosted their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. HSBC initiated coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 price target for the company. Finally, Citigroup boosted their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $95.09.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $86.72 on Thursday. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. The firm has a market cap of $39.57 billion, a price-to-earnings ratio of 28.72, a PEG ratio of 2.93 and a beta of 0.94. The company has a fifty day moving average price of $88.91 and a 200-day moving average price of $78.27.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.31 earnings per share. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s payout ratio is currently 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.